Browse > Article

Inhibition Effect of Taxilli Ramulus Extract on Osteoclast Differentiation and Bone Resorption  

Baek, Jong Min (Department of Anatomy, Institute for Environmental Science, Wonkwang University)
Kim, Ju Young (Institute for Skeletal Disease & Imaging Science-based Lung and Bone Diseases Research Center, Wonkwang University)
Lee, Myeung Su (Institute for Skeletal Disease & Imaging Science-based Lung and Bone Diseases Research Center, Wonkwang University)
Jeung, Woo Jin (Department of Anatomy, Institute for Environmental Science, Wonkwang University)
Moon, Seo Young (Division of Anesthesiology and Pain Medicine, Sanbon Medical Center)
Jeon, Byung Hoon (Department of Pathology, College of Korean Medicine & Research Center of Traditional Korean Medicine, Wonkwang University)
Oh, Jae Min (Department of Anatomy, Institute for Environmental Science, Wonkwang University)
Choi, Min Kyu (Department of Anatomy, Institute for Environmental Science, Wonkwang University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.27, no.4, 2013 , pp. 431-436 More about this Journal
Abstract
Bone homeostasis is maintained by co-ordination of bone-resorbing osteoclasts and bone-forming osteoblasts. Imbalance between osteoclasts and osteoblasts leads to many bone diseases such as osteoporosis, rheumatoid arthritis. Taxillus chinensis is a herb that has been widely used to improve bone health. However, the effect and mechanism of Taxillus chinensis extract on osteoclast differentiation and bone resportion has been unknown. Thus, We investigated the effect of Taxillus chinensis on expression of receptor activator of nuclear factor-${\kappa}B$ ligand (RANKL)-induced osteoclast differentiation and bone resorption. Also, the action of Taxillus chinensis on mechanisms relating to osteoclast differentiation was studied. In this results, we identified that Taxillus chinensis significantly inhibited RANKL-induced osteoclast differentiation and bone resportion. Moreover, Taxillus chinensis was suppressed the activation of NF-${\kappa}B$ in bone marrow macrophage treated RANKL and M-CSF. Taxillus chinensis was down-regulated the mRNA expression of c-Fos, nuclear factor of activated T-cells (NFAT)c1, osteoclast-associated receptor (OSCAR), tartrate-resistant acid phosphatase (TRAP). The cell adhesion-related molecules such as integrin ${\alpha}v$ and integrin ${\beta}3$, and the filamentous actin (F-actin) rings of mature osteoclasts-related molecules such as dendritic cell-specific transmembrane preotein (DC-STAMP) and cathepsin K are also suppressed. Taken together, these results indicated that Taxillus chinensis will be a good candidate to treat osteoclast-mediated bone diseases.
Keywords
Taxillus chinenesis; Osteoclast; Osteoporosis; Differentiation; Bone resorption;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Rodan, G.A., Martin, T.J. Therapeutic approaches to bone disease. Science 289: 1508-1514, 2000.   DOI   ScienceOn
2 Clowes, J.A., Eghbali-Fatourechi, G.Z., McCready, L., Oursler, M.J., Khosla, S., Riggs, B.L. Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. Osteoporos Int 20: 761-769, 2009.   DOI   ScienceOn
3 Mundy, G.R. Osteoporosis and inflammation. Nutr Rev 65: S147-S151, 2007.   DOI   ScienceOn
4 Boyle, W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 423: 337-342, 2003.   DOI   ScienceOn
5 Del Fattore A., Teti A., Rucci N. Osteoclast receptorsand signaling. Arch Biochem Biophys 473: 147-160, 2008.   DOI   ScienceOn
6 Lee, Z.H., Kim, H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305: 211-214, 2003.   DOI   ScienceOn
7 Melton, L.J. 3rd, Atkinson, E.J., O'Connor, M.K., O'Fallon, W.M., Riggs, B. Bone density and fracture risk in men. J Bone Miner Res 13: 1915-1923, 1998.   DOI   ScienceOn
8 Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugal, N., Yamamoto, M., Nagata, N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 18: 9-14, 1996.   DOI   ScienceOn
9 Khosla, S., Burr, D., Cauley, J., Dempster, D.W., Ebeling,P.R. Felsenberg, D., Gagel, R.F., Gilsanz, V., Guise, T., Koka, S., McCauley, L.K., McGowan, J., McKee, M.D., Mohla, S., Pendrys, D.G., Raisz, L.G., Ruggiero, S.L., Shafer, D.M., Shum, L., Silverman, S.L., Van Poznak, C.H., Watts, N., Woo, S.B., Shane, E. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22: 1479-1491, 2007.   DOI   ScienceOn
10 부일, 이제현, 최호영, 권동렬, 부영민. 韓藥本草學, 서울, 영림사 p 374; 375.
11 Jeong, J.H., Jeong, J,C. Effects of Taxilli Ramulus Extract on Bone Metabolism of Ethanol Treated Rats. J Korean Oriental Med 22(4):1-9, 2001.
12 David, J.P., Sabapathy, K., Hoffmann, O., Idarraga, M.H., Wagner, E.F. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci 115: 4317-4325, 2002.   DOI   ScienceOn
13 Chang, E.J., Ha, J., Huang, H., Kim, H.J., Woo, J.H., Lee, Y., Lee, Z.H., Kim, J.H., Kim, H.H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J Cell Sci 121: 2555-2564, 2008.   DOI   ScienceOn
14 Otero, J.E., Dai, S., Foglia, D., Alhawagri, M., Vacher, J., Pasparakis, M., Abu-Amer, Y. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem 283: 24546-24553, 2008.   DOI   ScienceOn
15 Wagner, E.F., Eferl, R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208: 126-140, 2005.   DOI   ScienceOn
16 Ikeda, F., Matsubara, T., Tsurukai, T., Hata, K., Nishimura, R., Yoneda, T. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. J Bone Miner Res 23: 907-914, 2008.
17 Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901, 2002.   DOI   ScienceOn
18 Eferl, R., Wagner, E.F. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003.   DOI   ScienceOn
19 Chelliaiah, M.A., Hruska, K.A. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72: 197-205, 2003.   DOI
20 Zeng, Z., Zhang, C., Chen, J. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts. J Bone Miner Metab [Epub ahead of print], 2013.
21 Ke, K., Kim, W.K., Sul, O.J., Phan, V.T., Lee, M.H., Kim, H.J., Kim, S.Y., Choi, H.S. Elevation of fibrinogen due to loss of ovarian function enhances actinring formation and leads to increased bone resorption. Am J Physiol Endocrinol Metab 303: E1296-E1303, 2012.   DOI   ScienceOn
22 Tanaka, H., Tanabe, N., Kawato, T., Nakai, K., Kariya, T., Matsumoto, S., Zhao, N., Motohashi, M., Maeno, M. Nicotine Affects Bone Resorption and Suppresses the Expression of Cathepsin K, MMP-9 and Vacuolar-Type H(+)-ATPase d2 and Actin Organization in Osteoclasts. PLoS One 8: e59402, 2013.   DOI
23 Ichiro, N.., Naoyuki, T., Takahisa, S., Eijiro, J., Takahide, K., Tatsuo S. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J Bone Miner Res 11: 1873-1879, 1996.